Shares of Insilico rose 45% in their Hong Kong trading debut after the AI drug discovery startup raised $293M in an IPO; Insilico reported $85M+ in 2024 revenue — Insilico Medicine Cayman TopCo shares rose on their trading debut in Hong Kong after raising $293 million in an initial public offering.
Posted from: this blog via Microsoft Power Automate.